← Back to headlines
Obesity Firm Kailera Therapeutics Stock Jumps 63% After IPO
Kailera Therapeutics, a company focused on obesity treatments, saw its stock price surge by 63% following its $625 million initial public offering.
17 Apr, 20:13 — 17 Apr, 20:13
Sources
Showing 1 of 1 sources
